Unichem's formulation facility at Goa and Baddi has received Good Manufacturing Practices (GMP) certificate from the Brazilian Regulatory Authority, ANVISA (Agencia Nacional de Vigilancia Sanitaria).

With this approval Unichem will be able to market its products in Brazil through its wholly owned subsidiary Unichem Farmaceutica Do Brasil Ltda. Goa and Baddi facilities also have approvals from MHRA-UK, MCC-South Africa. In addition to this Goa facility also has approvals from TGA-Australia and WHO-Geneva.

Unichem Labs is an Indian pharmaceutical company with vertically integrated operations. Unichem produces and markets finished dosage formulations and active pharmaceutical ingredients in anti-infective, cardiovascular, psychiatry and neurology, musculo-skeletal, gastro-intestinal, nutritional, anti-allergic and other therapeutic areas in India and overseas.